Medical costs for patients with rheumatoid arthritis who have comorbid diabetes mellitus.

ABSTRACT:

Objectives

To evaluate medical costs and resource use in patients with rheumatoid arthritis (RA) with and without diabetes mellitus (DM).

Methods

Data were obtained from the Japan Medical Data Center (JMDC) claims database. The baseline period comprised 6 months before the index date (first prescription date post-RA diagnosis) while the 12-month duration post-index date was the follow-up period. Patients with RA and DM prescribed an antidiabetic drug in the baseline period constituted the DM group, while patients with RA without DM or an antidiabetic prescription in the baseline and follow-up periods belonged to the non-DM group. Patients were matched by sex, age, Charlson Comorbidity Index (CCI), months from the first RA codes, and medications. The primary endpoint was tota

SUBMITTER: Tanaka E 

PROVIDER: S-EPMC12316215 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature